PMC:7405836 / 110950-111142 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7405836","sourcedb":"PMC","sourceid":"7405836","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7405836","text":"However, altering the vehicles used in the formulations, the pharmacokinetic properties can be modified, thereby having significant control over the systemic concentration of ivermectin (338).","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T184","span":{"begin":175,"end":185},"obj":"Chemical"}],"attributes":[{"id":"A184","pred":"chebi_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/CHEBI_6078"},{"subj":"T184","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T757","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T757","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#df93ec","default":true},{"id":"LitCovid-sentences","color":"#93ecc5"}]}]}}